Search Results

Filter

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification.

  • Authors : Nachtkamp K; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany. .; Strupp C

Subjects: Neoplasms* ; Myelodysplastic Syndromes*; Humans

  • Source: Leukemia [Leukemia] 2024 Feb; Vol. 38 (2), pp. 442-445. Date of Electronic Publication: 2024 Jan 23.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Inherited polygenic effects on common hematological traits influence clonal selection on JAK2 V617F and the development of myeloproliferative neoplasms.

  • Authors : Guo J; Wellcome Sanger Institute, Hinxton, UK.; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK.

Subjects: Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/diagnosis ; Neoplasms*

  • Source: Nature genetics [Nat Genet] 2024 Feb; Vol. 56 (2), pp. 273-280. Date of Electronic Publication: 2024 Jan 17.Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Utility of p53 immunohistochemistry as a surrogate for sequencing in myeloid neoplasms: A tale of caution.

  • Authors : Nahmod KA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sasaki K

Subjects: Myeloproliferative Disorders* ; Neoplasms*; Humans

  • Source: American journal of hematology [Am J Hematol] 2024 Feb; Vol. 99 (2), pp. 329-330. Date of Electronic Publication: 2023 May 27.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.

  • Authors : Pasquer H; Université Paris Cité, APHP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM CIC 1427, Paris, France.; INSERM UMR 944, Institut de Recherche Saint-Louis, Paris, France.

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/complications ; Venous Thrombosis*/Venous Thrombosis*/Venous Thrombosis*/genetics ; Thrombosis*/Thrombosis*/Thrombosis*/genetics

  • Source: Leukemia [Leukemia] 2024 Feb; Vol. 38 (2), pp. 326-339. Date of Electronic Publication: 2023 Dec 27.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Cytoreductive treatment and kidney vascular damage in patients with chronic myeloproliferative neoplasms.

  • Authors : Krecak I; Department of Internal Medicine, General Hospital of Sibenik-Knin County, Sibenik, Croatia; University of Applied Sciences, Sibenik, Croatia

Subjects: Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/complications ; Kidney Diseases* ; Neoplasms*

  • Source: Kidney international [Kidney Int] 2024 Apr; Vol. 105 (4), pp. 890.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print Cited Medium: Internet ISSN: 1523-1755

Record details

×
Editorial & Opinion

Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms.

  • Authors : Raskovalova T; Laboratoire d'immunologie, Université Grenoble Alpes, Grenoble University Hospital, Grenoble, France. .; Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France. .

Subjects: Neoplasms* ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/metabolism; Humans

  • Source: Leukemia [Leukemia] 2024 Apr; Vol. 38 (4), pp. 923-924. Date of Electronic Publication: 2024 Mar 14.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy.

  • Authors : Gurney M; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Baranwal A

Subjects: Receptors, Chimeric Antigen* ; Neoplasms* ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy

  • Source: JAMA oncology [JAMA Oncol] 2024 Apr 01; Vol. 10 (4), pp. 532-535.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Role of DNA Repair ( XPC , XPD , XPF , and XPG) Gene Polymorphisms in the Development of Myeloproliferative Neoplasms.

  • Authors : Crișan AS; Genetics Department, 'George Emil Palade' University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu 38, 540142 Targu Mures, Romania.; Genetics Laboratory, Center for Advanced Medical and Pharmaceutical Research, 'George Emil Palade' University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu 38, 540139 Targu Mures, Romania.

Subjects: DNA-Binding Proteins*/DNA-Binding Proteins*/DNA-Binding Proteins*/genetics ; Neoplasms*; Humans

  • Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Mar 19; Vol. 60 (3). Date of Electronic Publication: 2024 Mar 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144

Record details

×
Academic Journal

Familial bilateral macronodular adrenal hyperplasia due to a novel ARMC 5 germline mutation: Clinical status and possible association with other neoplasms.

Subjects: Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/complications ; Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/genetics ; Cushing Syndrome*/Cushing Syndrome*/Cushing Syndrome*/genetics

  • Source: Endocrinologia, diabetes y nutricion [Endocrinol Diabetes Nutr (Engl Ed)] 2024 Mar; Vol. 71 (3), pp. 119-123.Publisher: Country of Publication: Spain NLM ID: 101717565 Publication Model: Print Cited Medium: Internet ISSN: 2530-0180 (Electronic)

Record details

×
Academic Journal

Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.

  • Authors : Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ong F

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/epidemiology ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/epidemiology

  • Source: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7093.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×